-------------------------------------------------------------------------
REVENUE
-------------------------------------------------------------------------
Product sales 2,158 3,392
-------------------------------------------------------------------------
Licensing 1,061 2,021
-------------------------------------------------------------------------
3,219 5,413
-------------------------------------------------------------------------
-------------------------------------------------------------------------
EXPENSES
-------------------------------------------------------------------------
Cost of goods sold (excluding amortization) 951 1,701
-------------------------------------------------------------------------
Research and development expenses, net 5,691 4,468
-------------------------------------------------------------------------
Selling, general and administrative expenses 4,816 5,173
-------------------------------------------------------------------------
Financial expenses 711 549
-------------------------------------------------------------------------
Impairment loss on long-term investment 691 -
-------------------------------------------------------------------------
Depreciation and amortization 525 472
-------------------------------------------------------------------------
Interest income (652) (972)
-------------------------------------------------------------------------
<| SOURCE Labopharm Inc. Copyright©2008 PR Newswire. All rights reserved |